Investing Profile

Nilay Thakar

InvestorVC
Principal at ARCH Venture Partners
Photo of Nilay Thakar, Principal at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Robyn Frankel Network
341 CONNECTIONS
CILA THERAPEUTICS Network
86 CONNECTIONS
The University of Queensland Network
20 CONNECTIONS
The University of Queensland Network
20 CONNECTIONS
ARCH Venture Partners Network
15 CONNECTIONS
cb
$50K - $150.0M
$25.0M
$635.8M
Board Observer Robyn FrankelPresent
Board Observer CILA THERAPEUTICSPresent
Board Observer hC Bioscience, Inc.Present
Board Observer Doppler BioPresent
Board Observer Lifordi Immunotherapeutics, Inc.Present
Co-Founder and Head of BD Skylark BioPresent
Committee Member - Industry International Society for Stem Cell ResearchPresent
Board Observer Volastra TherapeuticsPresent
Board Observer SonoTheraPresent
Board Observer Lifordi ImmunotherapiesPresent
Co-Founder and Head of BD ARCH Stealth NewCoPresent
Commercialization Analyst Intern Dendright Pty LimitedPresent
Advisor - Theo Murphy High Flyers Think Tank The Australian Academy of SciencePresent
General Manager - Stem Cells Ltd Australian Institute for Bioengineering and Nanotechnology AIBNPresent
Principal ARCH Venture PartnersPresent
Board Member AgBiomePresent
Committee Member - Industry International Society for Stem Cell ResearchPresent
Board Observer One BioMed Pte LtdPresent
Board Observer Arbor BiotechnologiesPresent
Co-Founder and Head of Business Development ARCH Stealth NewCoPresent
The University of Queensland Bachelor of Science Honours Class 1 Biochemistry
The University of Queensland Doctor of Philosophy (Ph.D.) Stem Cell Biology